Abstract
The coronavirus disease 2019 (COVID-19) virus is spreading rapidly, and scientists are endeavoring to discover drugs for its efficacious treatment in China. Chloroquine phosphate, an old drug for treatment of malaria, is shown to have apparent efficacy and acceptable safety against COVID-19 associated pneumonia in multicenter clinical trials conducted in China. The drug is recommended to be included in the next version of the Guidelines for the Prevention, Diagnosis, and Treatment of Pneumonia Caused by COVID-19 issued by the National Health Commission of the People's Republic of China for treatment of COVID-19 infection in larger populations in the future.
Keywords
ChloroquineMedicineCoronavirus disease 2019 (COVID-19)PneumoniaClinical trialIntensive care medicineMalariaDrugDiseasePharmacologyInternal medicineImmunologyInfectious disease (medical specialty)
Affiliated Institutions
Related Publications
Review of Current Vaccine Development Strategies to Prevent Coronavirus Disease 2019 (COVID-19)
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) outbreak that started in Wuhan, China, in 2019 resulted in a pandemic not seen for a century, and there is an ur...
Persistent Symptoms in Patients After Acute COVID-19
This case series describes COVID-19 symptoms persisting a mean of 60 days after onset among Italian patients previously discharged from COVID-19 hospitalization.
First Case of 2019 Novel Coronavirus in the United States
An outbreak of novel coronavirus (2019-nCoV) that began in Wuhan, China, has spread rapidly, with cases now confirmed in multiple countries. We report the first case of 2019-nCo...
Publication Info
- Year
- 2020
- Type
- article
- Volume
- 14
- Issue
- 1
- Pages
- 72-73
- Citations
- 2645
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
2645
OpenAlex
Cite This
Jianjun Gao,
Zhenxue Tian,
Xu Yang
(2020).
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.
BioScience Trends
, 14
(1)
, 72-73.
https://doi.org/10.5582/bst.2020.01047
Identifiers
- DOI
- 10.5582/bst.2020.01047